Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / 조합 미르 세포 주기 조절 및 신생 치료의…
JoVE Journal
Cancer Research
Author Produced

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
조합 미르 세포 주기 조절 및 신생 치료의 분석
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Journal (Cancer Research)
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Journal (Cancer Research)
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
 
Click here for the English version

조합 미르 세포 주기 조절 및 신생 치료의 분석

Article DOI: 10.3791/59460-v • 11:44 min • March 30th, 2019
March 30th, 2019 •
1, 1, 2, 3, 1, 1, 2, 1
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, 2Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 3Department of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

miRNA 치료제 암 진행을 조절에 상당한 잠재력이 있다. 여기 설명 분석 접근 사용 된다 세포 주기 및 신생 중단 조합 미르 치료의 활동의 식별을 위해.

Tags

암 연구 문제 145 transfection 미르 폐 암 세포 주기 apoptosis 신생 RNA 시퀀싱
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter